Vaccines Industry Research Report 2024

Vaccines Industry Research Report 2024


Summary

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
According to APO Research, the global Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Vaccines segment by Type

Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Vaccines segment by Application

Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Vaccines Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Vaccines Sales (2019-2030)
2.2.3 Global Vaccines Market Average Price (2019-2030)
2.3 Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Recombinant Vaccines
2.3.3 Viral Vaccines
2.3.4 Polysaccharide Vaccines
2.3.5 Others
2.4 Vaccines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Rabies vaccine
2.4.3 Influenza vaccine
2.4.4 HPV vaccine
2.4.5 Hepatitis B
2.4.6 Hepatitis A
2.4.7 Leprosy vaccine
2.4.8 Polio vaccine
2.4.9 JE vaccine
2.4.10 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Vaccines Sales (K Pcs) of Manufacturers (2019-2024)
3.3 Global Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Vaccines, Product Type & Application
3.8 Global Manufacturers of Vaccines, Date of Enter into This Industry
3.9 Global Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK Vaccines Product Portfolio
4.1.5 GSK Recent Developments
4.2 Sanofi
4.2.1 Sanofi Company Information
4.2.2 Sanofi Business Overview
4.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sanofi Vaccines Product Portfolio
4.2.5 Sanofi Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Merck Vaccines Product Portfolio
4.3.5 Merck Recent Developments
4.4 Pfizer
4.4.1 Pfizer Company Information
4.4.2 Pfizer Business Overview
4.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Pfizer Vaccines Product Portfolio
4.4.5 Pfizer Recent Developments
4.5 Novartis(GSK)
4.5.1 Novartis(GSK) Company Information
4.5.2 Novartis(GSK) Business Overview
4.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Novartis(GSK) Vaccines Product Portfolio
4.5.5 Novartis(GSK) Recent Developments
4.6 CSL
4.6.1 CSL Company Information
4.6.2 CSL Business Overview
4.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 CSL Vaccines Product Portfolio
4.6.5 CSL Recent Developments
4.7 MedImmune LLC
4.7.1 MedImmune LLC Company Information
4.7.2 MedImmune LLC Business Overview
4.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 MedImmune LLC Vaccines Product Portfolio
4.7.5 MedImmune LLC Recent Developments
4.8 J&J(Crucell)
4.8.1 J&J(Crucell) Company Information
4.8.2 J&J(Crucell) Business Overview
4.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 J&J(Crucell) Vaccines Product Portfolio
4.8.5 J&J(Crucell) Recent Developments
4.9 China National Biotec
4.9.1 China National Biotec Company Information
4.9.2 China National Biotec Business Overview
4.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 China National Biotec Vaccines Product Portfolio
4.9.5 China National Biotec Recent Developments
4.10 Tiantan
4.10.1 Tiantan Company Information
4.10.2 Tiantan Business Overview
4.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Tiantan Vaccines Product Portfolio
4.10.5 Tiantan Recent Developments
4.11 Hualan
4.11.1 Hualan Company Information
4.11.2 Hualan Business Overview
4.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Hualan Vaccines Product Portfolio
4.11.5 Hualan Recent Developments
4.12 Kangtai
4.12.1 Kangtai Company Information
4.12.2 Kangtai Business Overview
4.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Kangtai Vaccines Product Portfolio
4.12.5 Kangtai Recent Developments
4.13 Hissen
4.13.1 Hissen Company Information
4.13.2 Hissen Business Overview
4.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Hissen Vaccines Product Portfolio
4.13.5 Hissen Recent Developments
4.14 Jintan
4.14.1 Jintan Company Information
4.14.2 Jintan Business Overview
4.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Jintan Vaccines Product Portfolio
4.14.5 Jintan Recent Developments
5 Global Vaccines Market Scenario by Region
5.1 Global Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Vaccines Sales by Region: 2019-2030
5.2.1 Global Vaccines Sales by Region: 2019-2024
5.2.2 Global Vaccines Sales by Region: 2025-2030
5.3 Global Vaccines Revenue by Region: 2019-2030
5.3.1 Global Vaccines Revenue by Region: 2019-2024
5.3.2 Global Vaccines Revenue by Region: 2025-2030
5.4 North America Vaccines Market Facts & Figures by Country
5.4.1 North America Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Vaccines Sales by Country (2019-2030)
5.4.3 North America Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Vaccines Market Facts & Figures by Country
5.5.1 Europe Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Vaccines Sales by Country (2019-2030)
5.5.3 Europe Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Vaccines Market Facts & Figures by Country
5.7.1 Latin America Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Vaccines Sales by Type (2019-2030)
6.1.1 Global Vaccines Sales by Type (2019-2030) & (K Pcs)
6.1.2 Global Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Vaccines Revenue by Type (2019-2030)
6.2.1 Global Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Vaccines Price by Type (2019-2030)
7 Segment by Application
7.1 Global Vaccines Sales by Application (2019-2030)
7.1.1 Global Vaccines Sales by Application (2019-2030) & (K Pcs)
7.1.2 Global Vaccines Sales Market Share by Application (2019-2030)
7.2 Global Vaccines Revenue by Application (2019-2030)
7.2.1 Global Vaccines Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Vaccines Revenue Market Share by Application (2019-2030)
7.3 Global Vaccines Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Vaccines Value Chain Analysis
8.1.1 Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Vaccines Production Mode & Process
8.2 Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Vaccines Distributors
8.2.3 Vaccines Customers
9 Global Vaccines Analyzing Market Dynamics
9.1 Vaccines Industry Trends
9.2 Vaccines Industry Drivers
9.3 Vaccines Industry Opportunities and Challenges
9.4 Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings